- . 'Omics' approaches in disease diagnosis and prognosis.
- . Computational models/simulations.
- . Disease models
- . Drug discovery
- . Epigenetic basis of human diseases
- . Gene therapy and CRISPR/Cas9 technology in
- . Hereditary and Metabolic disorders/syndromes.
- . Invasive/ non-invasive diagnostics.
- . Multi-drug resistance.
- . Nanobiotechnology.
- . Pathophysiology of communicable/non-communicable human diseases.
- . Repurposing of drugs or combinatorial drug regimen.
- . Stem cells and Regenerative Medicine.
- . Stress and Ageing.
- . Target identification and validation for prognosis/ therapeutics
# The last date for abstract submission (Oral/Poster) 25th February, 2020.